Clinical Trials
2 trialsNCT07150767 2025-12-02
A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer
Beijing Bio-Targeting Therapeutics Technology Co., Ltd
Phase 1 Withdrawn
NCT00286247 2008-04-01
Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer
Introgen Therapeutics
Phase 2 Completed